drugset / Trial / NCT00150215
A First In Human Study Of PF-00184562 In Healthy Volunteers
RandomizedCrossoverDouble-blindTreatment
Summary
The purposes of this study are: * To determine the safety, tolerability and pharmacokinetics of single doses of PF-00184562; and * To explore the exposure-response relationship of neuropsychometric and tolerability measures of PF-00184562 compared to olanzapine.
Timeline
- Start
- 2005-07
- Primary completion
- —
- Completion
- 2005-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Olanzapine | Small molecule | — | — |
| Subject | PF-00184562 | Unknown | — | Oral |